Salubris Pharmaceuticals

From Wikipedia, the free encyclopedia

Shenzhen Salubris Pharmaceuticals (Chinese: 深圳信立泰药业; pinyin: Shēnzhèn Xìnlìtài Yàoyè; SZSE: 002294) is a Chinese pharmaceutical company.

Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019.[1]

Shenzhen Salubris is headed by the billionaire Ye Chenghai.[2]

References[]

  1. ^ "Shenzhen Salubris Pharmaceuticals". Forbes. Retrieved 6 April 2019.
  2. ^ "Ye Chenghai". Forbes. Retrieved 16 May 2015.
Retrieved from ""